F PIRES MAXIMIANO… - Journal of pharmacy …, 2011 - cat.inist.fr Objectives Benznidazole (BNZ), the primary chemotherapy agent used to treat Chagas disease, has poor aqueous solubility, which results in low bioavailability. The purpose of this work was to develop stable effervescent tablets using an inclusion complex of BNZ with ...
S Elad, I Zeevi, J Finke, M Koldehoff… - Biology of Blood and …, 2011 - Elsevier Chronic graft-versus-host disease (cGVHD) frequently involves oral tissues. Although the mucosal changes may be painful and impair oral function, there is currently no topical therapy available for oral cGVHD that has been proven to work in an evidence-based manner. The aims of ... Related articles - All 3 versions
G D'andrea… - US Patent 20,110,217,276, 2011 - freepatentsonline.com ... 6. The composition as claimed in claim 1, in the form of a suspensible or effervescent powder, ordinary, multilayer, differentiated-release or gastroprotected tablets, medicated gum discs, effervescenttablets or melting powder. 7. 7-10. (canceled). Description: ... Cached
AK Bani-Jaber, MY Alkawareek… - Chemical & …, 2011 - J-STAGE Several approaches are used to prolong gastric retention time. These include polymeric bioadhesive systems,1) swelling and expanding systems,2,3) and floating drug deliv- ery systems.4,5) The principle of buoyant preparation offers a simple, practical approach to achieve increased ... Related articles - All 3 versions
K Zhongcheng, Z Dawei… - Journal of Huangshan …, 2011 - en.cnki.com.cn Via experiments,the ingredients and their ratio of Vitamin C effervescenttablets are selected and given initial evaluation.The Vitamin C effervescenttablets produced can meet the requirements in such aspects as disintegration time,hardness,weight and so on.The results show ... Cached
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
